These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16288068)

  • 1. Acute hypersensitivity reaction to ferric gluconate in a premedicated patient.
    Saadeh CE; Srkalovic G
    Ann Pharmacother; 2005 Dec; 39(12):2124-7. PubMed ID: 16288068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
    Sane R; Baribeault D; Rosenberg CL
    Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylactoid reaction to intravenous sodium ferric gluconate complex during pregnancy.
    Cuciti C; Mayer DC; Arnette R; Spielman FJ
    Int J Obstet Anesth; 2005 Oct; 14(4):362-4. PubMed ID: 16140521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran.
    Bastani B; Rahman S; Gellens M
    ASAIO J; 2002; 48(4):404-6. PubMed ID: 12141472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
    Charytan C; Schwenk MH; Al-Saloum MM; Spinowitz BS
    Nephron Clin Pract; 2004; 96(2):c63-6. PubMed ID: 14988600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity from intravenous iron products.
    Bircher AJ; Auerbach M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):707-23, x-xi. PubMed ID: 25017687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on adverse drug events associated with parenteral iron.
    Chertow GM; Mason PD; Vaage-Nilsen O; Ahlmén J
    Nephrol Dial Transplant; 2006 Feb; 21(2):378-82. PubMed ID: 16286429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
    Coyne DW; Adkinson NF; Nissenson AR; Fishbane S; Agarwal R; Eschbach JW; Michael B; Folkert V; Batlle D; Trout JR; Dahl N; Myirski P; Strobos J; Warnock DG;
    Kidney Int; 2003 Jan; 63(1):217-24. PubMed ID: 12472786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial.
    Vinson DR; Drotts DL
    Ann Emerg Med; 2001 Feb; 37(2):125-31. PubMed ID: 11174228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the relative safety of parenteral iron formulations.
    Chertow GM; Mason PD; Vaage-Nilsen O; Ahlmén J
    Nephrol Dial Transplant; 2004 Jun; 19(6):1571-5. PubMed ID: 15150356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of a high dose ferric gluconate in patients with severe chronic renal insufficiency.
    Jain AK; Bastani B
    J Nephrol; 2002; 15(6):681-3. PubMed ID: 12495284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
    Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
    Leehey DJ; Palubiak DJ; Chebrolu S; Agarwal R
    Nephrol Dial Transplant; 2005 Jan; 20(1):135-40. PubMed ID: 15522899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
    Bailie GR; Clark JA; Lane CE; Lane PL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1443-9. PubMed ID: 15855210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison trial of iron succinylprotein complex or iron gluconate complex in the treatment of iron deficiency anemia.
    Pedrazzoli P; Scotti A; Farina D
    Clin Ther; 1988; 10(4):414-20. PubMed ID: 3079009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of parenteral iron products and serious anaphylactic-type reactions.
    Wysowski DK; Swartz L; Borders-Hemphill BV; Goulding MR; Dormitzer C
    Am J Hematol; 2010 Sep; 85(9):650-4. PubMed ID: 20661919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis after Intravenous Ferric Gluconate: A Case Report.
    Botti M; Piperno A; Cianflone A; Mariani R
    Eur J Case Rep Intern Med; 2022; 9(4):003325. PubMed ID: 35520364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ferric gluconate complex given intravenously for iron deficiency in hemodialysis.
    Pascual J; Teruel JL; Liaño F; Sureda A; Ortuño J
    Clin Nephrol; 1991 Feb; 35(2):87. PubMed ID: 2019020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.